Nattokinase Powder 5000 FU UV

What is Nattokinase Powder 5000FU?

Nattokinase is an alkaline serine protease produced during the metabolism of Bacillus subtilis, a single-chain polypeptide structure without disulfide bonds, soluble in water, and yellowish or white in the solid state. The deoxyribonucleic acid (DNA) sequence of nattokinase consists of 275 amino acid residues, and its relative molecular mass is generally 28000u.

Nattokinase powder is a natural enzyme, also known as Bacillus subtilis fibrinolytic enzyme, QK fibrinolytic enzyme Nattokinase has fibrinolytic enzyme-like properties that break down fibrin. Nattokinase also stimulates the body's natural production of fibrinolytic enzymes to help support normal blood circulation, flow, and blood viscosity. Nattokinase is particularly sensitive to cross-linked fibrin (fibrin that has formed a blood clot) and can degrade it directly, with no effect on plasma fibrin and no risk of bleeding. Nattokinase has a diverse thrombolytic mechanism. In addition to the direct thrombolytic effect described above, there is a small indirect thrombolytic effect.

Green Spring Technology supplies Nattokinase Powder 5000 FU UV without vitamin K2 and without special ammonia odor. We use high quality pure strain Nattokinase fermentation, short production cycle, high yield, low price and easy to extract and purify. With an advanced scientific research team, experienced production management team, and professional sales team, Green Spring can customize various ratios of extracts as well as standard extracts as required. We have passed Halal, Kosher, COSMOS, BRC, IFS, FDA, ISO and other certifications. We can provide authoritative third-party test reports.

Specification: 

Regulations:

It conforms to EU regulations.

Benefits:

Reduces Blood Clot Formation

Clotting is formed through a series of chemical reactions between special blood cells (platelets) and proteins (clotting factors) in the blood and is an important defense mechanism for the body. Sometimes this process is abnormal and an abnormal clot (also known as a thrombus) develops in an artery or vein, blocking the flow of blood to surrounding tissues. Among these, acute arterial thrombosis is the proximal cause of most myocardial infarctions (heart attacks) and about 80% of strokes. In an open-label clinical trial (45 adults) with 3 groups, healthy, cardiovascular, and dialysis, all subjects were given 2 nattokinase capsules (nattokinase, a single dose of 2,000 FU) orally daily for 2 months.

The results found that coagulation factors associated with cardiovascular disease, such as fibrinogen, coagulation factor VII, and coagulation factor VIII, decreased consistently and at similar rates in all groups. Another double-blind, placebo-controlled trial (in 12 healthy young men) noted that D-dimer concentrations and blood fibrin/fibrinogen degradation products were elevated in subjects taking oral nattokinase and that the duration of action was longer (~8 hours or more).

Conclusion: Oral nattokinase may have a positive effect on inhibiting thrombosis, but more large trials are needed to confirm its clinical benefit, limited by the small sample size.

Prevention of Atherosclerosis

Atherosclerosis is a chronic disease in which arteries harden through plaque formation. Major risk factors include dyslipidaemia, diabetes, smoking, hypertension and genetic abnormalities. A randomised controlled trial (26 weeks in 82 patients with hyperlipidaemia) was conducted with two groups, one given a lipid-lowering drug: simvastatin, and the other given nattokinase (6000 FU daily dose).

After the test, it was found that the common carotid artery intima-media thickness (CCA-IMT) and carotid plaque size decreased in both groups, but the magnitude was more significant in the nattokinase group. In addition, lipid indices such as TG, TC and LDL-C decreased in both groups, but the magnitude was more significant in the simvastatin group, while nattokinase powder was able to increase HDL-C.

Conclusion: Oral nattokinase may be useful in the prevention of atherosclerosis, but due to the small sample size, more large-scale trials are needed to confirm the clinical benefits.

Liver Protection

After Nattokinase powder enters the human body, it builds an alcohol protection barrier through a triple channel: it enters the human liver system to break down the pressure on the liver to resolve alcohol and assist in alcohol detoxification; it enters the human vascular system to form a key protection barrier in the cerebrovascular region to resist the inhibitory effect of alcohol on the brain; and it enters the human digestive tract system to form a protective barrier rapidly to accelerate the acidic secretion of the digestive tract and promote alcohol detoxification.

Taking Natto can quickly solve the adverse effects of alcohol and prevent next-day drunkenness. In addition, a variety of active substances in natto activate liver cells, promote liver cell regeneration, improve liver function, protect the liver, and effectively prevent and improve fatty liver.

Applications:

For Health Products:

Nattokinase powder is widely used as a food supplement for blood thinning, prevention of thrombosis, and improvement of blood circulation in Japan, China, Korea, EU countries, Canada, and the United States. Nattokinase also has a variety of pharmacological effects such as improving microcirculation, lowering blood pressure, anticoagulation, preventing atherosclerosis, easing retinal angiogenesis, anticancer, and inhibiting inflammation and oxidative stress. It has been used as a nutraceutical additive.